跳至主要内容
临床试验/CTRI/2020/03/024011
CTRI/2020/03/024011尚未招募2 期

Efficacy of Unani Formulation in Zeequn Nafas (Bronchial Asthma): An Open Labelled Interventional Clinical Trial

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient with symptoms of Wheeze, Cough with expectoration, Mild to moderate
  • Paroxysmal Dyspnoea
  • 2.Mild to moderate asthma
  • 3.Patients who have consented for the study

排除标准

  • 1.Patients below 18 and above 50 years of age
  • 2.Acute or Severe Exacerbation(FEV1 or PEF < 40% predicted)
  • 3.Patients with Systemic illnesses such as HTN, IHD, DM
  • 4.Patients with a History of Allergic Rhinitis, COPD, Pneumonia, Occupational lung
  • diseases,Pulmonary tuberculosis
  • 5.Pregnant and lactating women
  • 6.Patients who had received corticosteroids, Bronchodilators or CAM therapy within
  • 2weeks prior to enrolment
  • 7.Patients who have not consented for the study

研究者

发起方
ational Institute of Unani Medicine

相似试验